JPH0121830B2 - - Google Patents

Info

Publication number
JPH0121830B2
JPH0121830B2 JP58170862A JP17086283A JPH0121830B2 JP H0121830 B2 JPH0121830 B2 JP H0121830B2 JP 58170862 A JP58170862 A JP 58170862A JP 17086283 A JP17086283 A JP 17086283A JP H0121830 B2 JPH0121830 B2 JP H0121830B2
Authority
JP
Japan
Prior art keywords
compound
general formula
formula
acid
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58170862A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6061580A (ja
Inventor
Muneaki Takase
Kimitomo Yoshioka
Hirosuke Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zenyaku Kogyo KK
Original Assignee
Zenyaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zenyaku Kogyo KK filed Critical Zenyaku Kogyo KK
Priority to JP58170862A priority Critical patent/JPS6061580A/ja
Priority to EP84110868A priority patent/EP0138058B1/en
Priority to DE8484110868T priority patent/DE3473453D1/de
Priority to US06/650,530 priority patent/US4565813A/en
Priority to CA000463160A priority patent/CA1226286A/en
Publication of JPS6061580A publication Critical patent/JPS6061580A/ja
Publication of JPH0121830B2 publication Critical patent/JPH0121830B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP58170862A 1983-09-16 1983-09-16 新規１，４−チアジン誘導体とその製造法 Granted JPS6061580A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP58170862A JPS6061580A (ja) 1983-09-16 1983-09-16 新規１，４−チアジン誘導体とその製造法
EP84110868A EP0138058B1 (en) 1983-09-16 1984-09-12 Novel 1,4-thiazine derivative
DE8484110868T DE3473453D1 (de) 1983-09-16 1984-09-12 Novel 1,4-thiazine derivative
US06/650,530 US4565813A (en) 1983-09-16 1984-09-14 1,4-Thiazine derivatives
CA000463160A CA1226286A (en) 1983-09-16 1984-09-14 1,4-thiazine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58170862A JPS6061580A (ja) 1983-09-16 1983-09-16 新規１，４−チアジン誘導体とその製造法

Publications (2)

Publication Number Publication Date
JPS6061580A JPS6061580A (ja) 1985-04-09
JPH0121830B2 true JPH0121830B2 (2) 1989-04-24

Family

ID=15912686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58170862A Granted JPS6061580A (ja) 1983-09-16 1983-09-16 新規１，４−チアジン誘導体とその製造法

Country Status (5)

Country Link
US (1) US4565813A (2)
EP (1) EP0138058B1 (2)
JP (1) JPS6061580A (2)
CA (1) CA1226286A (2)
DE (1) DE3473453D1 (2)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233287B1 (en) 1984-10-04 1991-01-30 Zenyaku Kogyo Kabushikikaisha 1,4-thiazine derivatives, process for their preparation, and cardiotonics containing the same
WO1991018893A1 (fr) * 1990-06-01 1991-12-12 Zenyaku Kogyo Kabushiki Kaisha Nouveau derive de 1,4-thiazine et cardiotonique contenant ce compose comme ingredient actif
JP3386235B2 (ja) * 1994-06-30 2003-03-17 株式会社リコー 転写紙案内装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1266464A (fr) * 1956-07-20 1961-07-17 Sterling Drug Inc Procédé de préparation des 2-aryl-4-métathiazanones et de certains de leurs dérivés
CS216535B2 (en) * 1978-10-16 1982-11-26 Lilly Co Eli Fungicide means and means for regulation of the water plants growth and method of making the active substances
US4476311A (en) * 1980-03-12 1984-10-09 The Purdue Frederick Company Analgesic 4-carboxy-pyrrolidin-2-one compound

Also Published As

Publication number Publication date
JPS6061580A (ja) 1985-04-09
US4565813A (en) 1986-01-21
DE3473453D1 (de) 1988-09-22
CA1226286A (en) 1987-09-01
EP0138058B1 (en) 1988-08-17
EP0138058A1 (en) 1985-04-24

Similar Documents

Publication Publication Date Title
US4291037A (en) 7-(Oxoalkyl)-1,3-di-n-iso-propyl xanthines and their production
DE69027235T2 (de) Xanthinderivate
KR910005233B1 (ko) 피리다지논 유도체
DE69223736T2 (de) Acridine-1,8-Dionderivate als therapeutisches Mittel
FR2573075A1 (fr) Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique
TW202542158A (zh) 稠環化合物、包含其的藥物組合物及其用途
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
LU80458A1 (fr) Nouveaux derives de phtalazine,leur procede de production,et composition pharmaceutique les contenant
LU82728A1 (fr) 6-(pyridinyl)-3(2h)pyridazinones,leur preparation et leur utilisation therapeutique
DE69101330T2 (de) Mit einem heterocyclischen Ring substituierte Cycloalkano[b]dihydroindole und -indolsulfonamide.
CA1178589A (fr) Derives de la (piperidyl-4)-2 (quinolyl-4)-1 ethanone procedes pour leur preparation, et leur utilisation comme medicaments
SU1356962A3 (ru) Способ получени производных карбостирила
JPH0121830B2 (2)
DE69221634T2 (de) 5-Piperazinylalkyl)-1,5-Benzothiazepinone verwendbar als Calciumantagonisten
JPH072793A (ja) 複素環式化合物
DE69516257T2 (de) 1,4-Benzoxazinderivate, es enthaltende pharmazeutische Zusammensetzung und seine Verwendung
CH633010A5 (fr) Derives de l'isoquinoleine, leur preparation et medicament qui les contient.
LU83032A1 (fr) 3-acylamino-5(pyridinyl)-2(1h)-pyridinones,leur preparation et leur utilisation comme agents cardiotoniques
CZ298196A3 (en) (s)-(-)-2-trifluoromethyl-4-(3-cyanphenyl)-4,6,7,8-tetrahydro-5(1h)- -quinolone, process of its preparation, pharmaceutical compositions containing thereof and its use
FR2742155A1 (fr) Utilisation de derives heteroaromatiques et tricycliques du 1,4-dihydro-1,4-dioxonaphtalene, nouveaux composes obtenus et leur application en therapeutique
LU82997A1 (fr) 6-(pyridinyl)-pyridazines,leur preparation et leur utilisation therapeutique
JP3009716B2 (ja) 新規なカンプトテシン誘導体
JP2535533B2 (ja) ベンゾジオキソ−ル誘導体
FR2542741A1 (fr) 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine
WO1986002074A1 (fr) Nouveaux derives de 1,4-thiazine, leur procede de preparation et cardiotoniques les contenant